Obesity and overweight: Developing drugs and biological products for weight reduction
Tirzepatide, present in both Mounjaro and Zepbound, acts on the body to manage weight and diabetes through dual-action receptor mechanisms: GLP-1 Receptor Effects: This reduces appetite, slows gastric emptying, and regulates insulin release based on elevated blood sugar levels
Its important to follow the prescribed titration schedule and speak to your clinician if symptoms are difficult to manage
Of note, this muscle mass loss is a side effect of rapid weight loss and not necessarily a direct side effect of the medications
For patients currently in compounded GLP-1 programs, the transition would likely involve one of several options: switching to an FDA-approved branded medication (at substantially higher cost), discussing alternative weight management approaches with a licensed provider, or exploring whether 503A patient-specific compounding applies to their individual clinical situation
Circ J 72:926931